SEC Form 4 · accession 0001193125-26-346966
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nishant C Saxena
Officer — Chief Business Officer
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | Aug 11, 2026 | P | 2,600 | $9.6294 | A | 77,900 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported.